Comparison of LASIK and contact lenses for myopia correction
Higher Education Press
image:
Flowchart of literature selection.
view moreCredit: HIGHER EDUCATION PRESS
Myopia affects billions of people worldwide. LASIK surgery offers long-term vision correction by reshaping the cornea, while contact lenses provide a flexible, reversible option but need daily care. Previous studies rarely compared these two methods directly. This review followed PRISMA guidelines and searched four databases. Four studies with 2,141 participants (1,275 LASIK users, 866 contact lens users) were included. The main outcome was quality of life, with secondary outcomes being patient satisfaction and dry eye.
LASIK showed moderate improvement in quality of life, but results varied across studies. After removing one all-female study, the remaining studies consistently favored LASIK. Patient satisfaction strongly favored LASIK (88% vs. 54%), and 97% of former contact lens users preferred LASIK after switching. Complication rates were lower for LASIK (6.7%–9.5% vs. 19.9%). However, LASIK caused more acute dry eye (50%–58%), while contact lenses caused more chronic dry eye (71%).
LASIK is better for satisfaction and safety, but quality of life results are not clear enough due to different measurement tools. For individuals with dry eye symptoms or other ocular surface issues, the appropriate correction method should be determined by a professional physician after a thorough assessment of the ocular surface condition and a comprehensive evaluation.
The work titled “Quality of Life in Myopia: Laser-Assisted In Situ Keratomileusis Versus Contact Lenses”, was published on Eye & ENT Research (published on June 24, 2026).
Journal
Eye & ENT Research
Method of Research
Experimental study
Subject of Research
Not applicable
Article Title
Quality of Life in Myopia: Laser-Assisted In Situ Keratomileusis Versus Contact Lenses
Spectacle lenses with highly aspherical lenslets for myopia control
JAMA Ophthalmology
About the Study:
In this randomized clinical trial of US children, spectacle lenses with HAL provided a reduction in myopia progression and axial elongation over 24 months. While longer-term data are needed to evaluate sustained treatment efficacy, these findings support HAL as a safe and effective myopia control intervention and underlie US Food and Drug Administration authorization of the study device.
Corresponding Author: Jason Shen, PhD, Essilor International, affiliate of EssilorLuxottica 13555 N Stemmons Fwy, Dallas, TX 75234 (Jason.shen@essilorusa.com).
10.1001/jamaophthalmol.2026.3288
To access the embargoed study: Visit our JAMA Network Media Center at this link https://media.jamanetwork.com/
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Editor's Note: Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Journal
JAMA Ophthalmology
No comments:
Post a Comment